HOLX – Hologic, Inc.
HOLX — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
3.23
Margin Of Safety %
19
Put/Call OI Ratio
4.18
EPS Next Q Diff
0.07
EPS Last/This Y
1.93
EPS This/Next Y
-0.65
Price
76.03
Target Price
76.5
Analyst Recom
3.08
Performance Q
1.94
Upside
-30.2%
Beta
0.76
Ticker: HOLX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | HOLX | 75.6 | 3.50 | 65.53 | 32305 |
| 2026-03-10 | HOLX | 75.54 | 3.75 | 1.32 | 34710 |
| 2026-03-11 | HOLX | 75.42 | 3.70 | 8.99 | 35411 |
| 2026-03-12 | HOLX | 75.2 | 3.68 | 999.99 | 35656 |
| 2026-03-13 | HOLX | 75.21 | 3.68 | 25.50 | 35656 |
| 2026-03-17 | HOLX | 75.05 | 3.80 | 22.89 | 36961 |
| 2026-03-18 | HOLX | 75.14 | 3.80 | 100.50 | 37282 |
| 2026-03-19 | HOLX | 75.34 | 3.78 | 6.45 | 37105 |
| 2026-03-20 | HOLX | 75.4 | 3.80 | 1.21 | 38412 |
| 2026-03-23 | HOLX | 75.62 | 3.67 | 14.54 | 28395 |
| 2026-03-24 | HOLX | 75.53 | 3.98 | 34.95 | 30840 |
| 2026-03-25 | HOLX | 75.54 | 4.07 | 6.00 | 31692 |
| 2026-03-26 | HOLX | 75.68 | 4.08 | 9.35 | 31793 |
| 2026-03-27 | HOLX | 75.65 | 4.14 | 2.22 | 32190 |
| 2026-03-30 | HOLX | 75.56 | 4.12 | 28.60 | 32154 |
| 2026-03-31 | HOLX | 75.55 | 4.16 | 4.00 | 32436 |
| 2026-04-01 | HOLX | 75.61 | 4.18 | 49.75 | 32422 |
| 2026-04-02 | HOLX | 75.63 | 4.18 | 999.99 | 32467 |
| 2026-04-06 | HOLX | 76.03 | 4.18 | 5.59 | 32467 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | HOLX | 75.60 | 2.4 | 311.7 | 4.42 |
| 2026-03-10 | HOLX | 75.54 | 2.4 | 312.8 | 4.42 |
| 2026-03-11 | HOLX | 75.42 | 2.4 | 312.0 | 4.42 |
| 2026-03-12 | HOLX | 75.20 | 2.4 | 310.6 | 4.42 |
| 2026-03-13 | HOLX | 75.11 | 2.4 | 312.2 | 4.42 |
| 2026-03-17 | HOLX | 75.07 | 2.4 | 312.5 | 4.42 |
| 2026-03-18 | HOLX | 75.15 | 2.4 | 315.1 | 4.42 |
| 2026-03-19 | HOLX | 75.35 | 2.4 | 117.6 | 4.42 |
| 2026-03-20 | HOLX | 75.41 | 2.4 | 116.3 | 4.42 |
| 2026-03-23 | HOLX | 75.62 | 2.4 | 117.8 | 4.42 |
| 2026-03-24 | HOLX | 75.54 | 2.4 | 114.1 | 4.42 |
| 2026-03-25 | HOLX | 75.54 | 2.4 | 115.2 | 4.43 |
| 2026-03-26 | HOLX | 75.68 | 2.4 | 117.2 | 4.43 |
| 2026-03-27 | HOLX | 75.65 | 2.4 | 114.9 | 4.43 |
| 2026-03-30 | HOLX | 75.56 | 2.4 | 114.2 | 4.43 |
| 2026-03-31 | HOLX | 75.56 | 2.4 | 115.7 | 4.43 |
| 2026-04-01 | HOLX | 75.63 | 2.4 | 116.3 | 4.43 |
| 2026-04-02 | HOLX | 75.64 | 2.4 | 115.9 | 4.43 |
| 2026-04-06 | HOLX | 76.02 | 2.4 | 120.0 | 4.43 |
| 2026-04-07 | HOLX | 76.03 | 2.4 | 120.0 | 4.43 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | HOLX | -4.04 | -1.97 | 2.20 |
| 2026-03-10 | HOLX | -4.04 | -1.97 | 2.20 |
| 2026-03-11 | HOLX | -4.04 | -1.97 | 3.78 |
| 2026-03-12 | HOLX | -4.04 | -1.97 | 3.78 |
| 2026-03-13 | HOLX | -4.04 | -1.97 | 3.78 |
| 2026-03-17 | HOLX | -4.04 | -2.04 | 3.78 |
| 2026-03-18 | HOLX | -4.04 | -2.04 | 3.78 |
| 2026-03-19 | HOLX | -4.04 | -2.04 | 3.78 |
| 2026-03-20 | HOLX | -4.04 | -2.04 | 3.78 |
| 2026-03-23 | HOLX | -4.04 | -1.98 | 3.78 |
| 2026-03-24 | HOLX | -0.21 | -1.98 | 3.78 |
| 2026-03-25 | HOLX | -0.21 | -1.98 | 3.23 |
| 2026-03-26 | HOLX | -0.21 | -1.98 | 3.23 |
| 2026-03-27 | HOLX | -0.21 | -1.98 | 3.23 |
| 2026-03-30 | HOLX | -0.21 | -1.93 | 3.23 |
| 2026-03-31 | HOLX | -0.21 | -1.93 | 3.23 |
| 2026-04-01 | HOLX | -0.21 | -1.93 | 3.23 |
| 2026-04-02 | HOLX | -0.21 | -1.93 | 3.23 |
| 2026-04-06 | HOLX | -0.21 | -1.94 | 3.23 |
| 2026-04-07 | HOLX | -0.21 | -1.94 | 3.23 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.04
Avg. EPS Est. Current Quarter
1.05
Avg. EPS Est. Next Quarter
1.11
Insider Transactions
-0.21
Institutional Transactions
-1.94
Beta
0.76
Average Sales Estimate Current Quarter
1032
Average Sales Estimate Next Quarter
1054
Fair Value
90.36
Quality Score
85
Growth Score
70
Sentiment Score
69
Actual DrawDown %
13.5
Max Drawdown 5-Year %
-39.9
Target Price
76.5
P/E
31.54
Forward P/E
15.82
PEG
2.36
P/S
4.11
P/B
3.23
P/Free Cash Flow
17.73
EPS
2.41
Average EPS Est. Cur. Y
4.43
EPS Next Y. (Est.)
3.78
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
13.18
Relative Volume
Return on Equity vs Sector %
-17.1
Return on Equity vs Industry %
0.8
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
120
◆
HOLX
Healthcare
$76.01
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
68.7
Range 1M
94.4%
Sup Dist
0%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
3.6%
EPS NY
8.9%
52W%
99.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+10.5% upside
Upside
+10.5%
Quality
85
MoS
19%
Hologic, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 7070
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analysis software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology systems; and breast conserving surgery products. In addition, the company provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system. The company sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
HOLX
Latest News
—
Caricamento notizie per HOLX…
stock quote shares HOLX – Hologic, Inc. Stock Price stock today
news today HOLX – Hologic, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch HOLX – Hologic, Inc. yahoo finance google finance
stock history HOLX – Hologic, Inc. invest stock market
stock prices HOLX premarket after hours
ticker HOLX fair value insiders trading